Theradiag launches €5.3 million rights issue
PARIS, FRANCE: Theradiag, a company specializing in in vitro diagnostics and Theranostics, announced the launch of a rights issue for a target amount of €5.3...
Serneke’s rights issue oversubscribed
STOCKHOLM: Serneke Group AB announced that the Company’s subscription ratio in the rights issue amounts to 187 percent. The subscription period for the rights issue...
AVEVA announces £2.835 billion rights issue to partly fund the acquisition of OSIsoft LLC
LONDON: AVEVA Group plc announced a fully committed and underwritten rights issue to raise gross proceeds of approximately £2.835 billion to partly fund the acquisition...